| Industry Range | | Price / Earnings | N/A | |
| Book Value | 4.16 | |
| Earnings Per Share | -$1.96 | |
| Price To Sales Ratio | 27.29 | |
| Price To Book Ratio | 4.00 | |
| Price To Tangible Book Ratio | 4.06 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 338.5M | |
| Float (MRQ) | 78.56% | |
| Shares Outstanding (MRQ) | 44.5M | |
| Short Interest as a % of Float (MRQ) | 6.52% | |
| Shares Held By Institutions (MRQ) | 22.5M | |
| Industry Range | | Sales | $38.7M | |
| Gross Margin | 89.21% | |
| Net Profit Margin | -224.55% | |
| EBIT Margin | -206.23% | |
| EBITDA Margin | -184.98% | |
| Operating Margins | -206.23% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 2.69 | |
| Quick Ratio (MRQ) | 2.69 | |
| Total Debt/Equity Ratio (MRQ) | 15.13 | |
| Debt/Common Equity Ratio (MRQ) | 15.13 | |
| Industry Range | | Return on Equity | -47.00% | |
| Return on Assets | -49.00% | |
| Asset Turnover | 0.22 | |
| Receivables Turnover | 2.21 | |
| Inventory Turnover | N/A | |
| Industry Range | | EPS Growth Annual | 19.39% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*MGTX does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 1.49%